Income Statement (TTM)
Oramed Pharmaceuticals Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 11-30 |
2020 12-31 |
2021 02-28 |
2021 05-31 |
2021 08-31 |
2021 11-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 0 | 0 | 2 | 2 |
| Change (%) | 0.07 | -0.41 | 0.00 | 0.07 | 0.00 | 0.33 | 0.00 | 0.00 | 0.00 | -0.33 | 0.00 | 0.00 | -25.23 | -33.70 | -49.70 | -100.00 | NaN | ∞ | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | ||
| Cost Of Sales | 2 | 2 | ||||||||||||||||||
| Change (%) | 0.00 | |||||||||||||||||||
| % of Revenue | 99.35 | 99.35 | ||||||||||||||||||
| Gross Operating Profit | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
| Change (%) | 0.07 | -0.41 | 0.00 | 0.07 | 0.00 | 0.33 | 0.00 | 0.00 | 0.00 | -0.33 | 0.00 | 0.00 | -25.23 | -33.70 | -49.70 | -100.00 | NaN | ∞ | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 0.65 | 0.65 | ||
| SG&A | 4 | 5 | 4 | 4 | 6 | 8 | 13 | 18 | 19 | 20 | 16 | 11 | 11 | 9 | 8 | 8 | 8 | 6 | 7 | 7 |
| Change (%) | 21.92 | -12.20 | 6.43 | 34.38 | 26.90 | 66.96 | 39.59 | 5.62 | 7.78 | -21.64 | -29.59 | -2.43 | -14.76 | -11.26 | 4.13 | -11.22 | -14.48 | 8.50 | -3.41 | |
| % of Revenue | 143.10 | 174.34 | 153.68 | 163.57 | 219.64 | 278.73 | 463.83 | 647.46 | 683.81 | 737.02 | 579.43 | 407.95 | 398.04 | 453.79 | 607.31 | 1,257.27 | 349.05 | 337.15 | ||
| R&D | 14 | 21 | 15 | 18 | 21 | 22 | 27 | 27 | 33 | 32 | 28 | 26 | 19 | 14 | 9 | 6 | 5 | 7 | 7 | 7 |
| Change (%) | 47.76 | -29.67 | 24.61 | 15.88 | 3.03 | 25.37 | -1.22 | 22.33 | -2.26 | -13.68 | -5.10 | -28.05 | -23.26 | -38.05 | -36.21 | -6.62 | 24.05 | 10.89 | -5.55 | |
| % of Revenue | 516.13 | 762.06 | 538.17 | 670.60 | 776.51 | 800.04 | 999.67 | 987.43 | 1,207.96 | 1,180.72 | 1,022.53 | 970.40 | 698.19 | 716.58 | 669.48 | 849.11 | 367.55 | 347.15 | ||
| OpEx | 18 | 25 | 19 | 23 | 27 | 29 | 40 | 44 | 51 | 52 | 43 | 37 | 30 | 24 | 17 | 14 | 13 | 13 | 16 | 16 |
| Change (%) | 42.15 | -26.41 | 20.57 | 19.51 | 8.29 | 36.12 | 11.71 | 15.71 | 1.37 | -16.74 | -13.96 | -20.47 | -20.17 | -27.67 | -17.02 | -9.37 | 1.52 | 24.93 | -3.96 | |
| % of Revenue | 659.23 | 936.39 | 691.85 | 834.17 | 996.15 | 1,078.76 | 1,463.50 | 1,634.88 | 1,891.78 | 1,917.74 | 1,601.96 | 1,378.36 | 1,096.23 | 1,170.36 | 1,276.79 | 2,106.38 | 815.95 | 783.65 | ||
| Operating Income | -15 | -23 | -16 | -20 | -24 | -26 | -37 | -42 | -49 | -49 | -41 | -35 | -27 | -22 | -16 | -14 | -13 | -13 | -14 | -14 |
| Change (%) | 49.67 | -29.52 | 24.05 | 22.15 | 9.22 | 39.77 | 12.57 | 16.74 | 1.45 | -17.65 | -14.89 | -22.07 | -19.67 | -27.10 | -14.24 | -4.85 | 1.52 | 9.61 | -4.51 | |
| % of Revenue | -559.23 | -836.39 | -591.85 | -734.17 | -896.15 | -978.76 | -1,363.50 | -1,534.88 | -1,791.78 | -1,817.74 | -1,501.96 | -1,278.36 | -996.23 | -1,070.36 | -1,176.79 | -2,006.38 | -715.95 | -683.65 | ||
| Interest Expense | -0 | -0 | -1 | -2 | -3 | -3 | -2 | -0 | 0 | |||||||||||
| Change (%) | 146.61 | 29.06 | 9.93 | -28.58 | -87.35 | -100.00 | ||||||||||||||
| % of Revenue | -2.54 | -6.47 | -40.87 | -152.01 | -390.06 | -13.05 | 0.00 | |||||||||||||
| Net Income | -15 | -22 | -15 | -18 | -22 | -25 | -35 | -40 | -46 | -46 | -37 | -30 | -20 | -16 | 6 | 10 | 21 | 4 | -28 | -24 |
| Change (%) | 51.13 | -29.65 | 18.91 | 20.98 | 10.43 | 42.54 | 13.58 | 16.89 | -0.42 | -21.00 | -19.23 | -31.62 | -19.01 | -133.78 | 89.25 | 99.52 | -78.60 | -732.43 | -14.43 | |
| % of Revenue | -536.46 | -810.18 | -572.31 | -680.53 | -822.72 | -908.55 | -1,290.71 | -1,466.04 | -1,713.68 | -1,706.42 | -1,352.61 | -1,092.53 | -747.02 | -809.20 | 412.31 | 1,551.34 | -1,411.90 | -1,208.10 | ||
Source: Capital IQ
